A carregar...
Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance
Pancreatic cancer is one of the most lethal types of cancer, due to difficulty in early detection and the limited efficacy of available treatments. Erlotinib is used to inhibit the epidermal growth factor receptor for the treatment of pancreatic cancer; however, erlotinib resistance is a major issue...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5431587/ https://ncbi.nlm.nih.gov/pubmed/28529573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5940 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|